Evidence map›Paper›PMID 40548053›Full record

ArticleFrontiers in pharmacology2025

Insights on pediatric medication initiation: perceptions of caregivers and children.

Maria Rubio-Valera, Cristina Carbonell-Duacastella, Maite Peñarrubia-María, Eva Pacheco, Patricia Gabriela-Ricciardeli, Ignacio Aznar-Lou, Montserrat Gil-Girbau

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maria Rubio-ValeraHealth Technology Assessment in Primary Care and Mental Health (PRISMA) Research Group, Teaching, Research and Innovation Unit, Institut de Recerca Sant Joan de Déu, de Llobregat, Spain.
Cristina Carbonell-DuacastellaHealth Technology Assessment in Primary Care and Mental Health (PRISMA) Research Group, Teaching, Research and Innovation Unit, Institut de Recerca Sant Joan de Déu, de Llobregat, Spain.
Maite Peñarrubia-MaríaCIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Eva PachecoFundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
Patricia Gabriela-RicciardeliParc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Spain.
Ignacio Aznar-LouHealth Technology Assessment in Primary Care and Mental Health (PRISMA) Research Group, Teaching, Research and Innovation Unit, Institut de Recerca Sant Joan de Déu, de Llobregat, Spain.
Montserrat Gil-GirbauHealth Technology Assessment in Primary Care and Mental Health (PRISMA) Research Group, Teaching, Research and Innovation Unit, Institut de Recerca Sant Joan de Déu, de Llobregat, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Children fail to initiate a high proportion of medications but little is known about motivations for non-initiation. Objective: To explore the factors affecting the decision to initiate a medication prescribed to children from caregivers' and children's perspectives. Methods: Qualitative study based on Grounded theory using a constructivist approach. Twenty-one caregivers and six children (<18 years old) were individually interviewed between 2021 and 2022 in Spain using a semi-structured thematic guide. Interviews were transcribed and analyzed by pharmacists, pediatricians and family physicians through a constant comparative analysis and results were internally audited. Results: Caregivers and healthcare professionals are the central figures involved in the decision-making process regarding treatment initiation; children were rarely involved. Caregivers, usually mothers, made a risk-benefit evaluation based on the perception of the disease and the medication, which was influenced by intrapersonal factors (emotional burden, health literacy and stigma); children-related factors (age, treatment and emotional burden); and factors related to the professionals (accessibility, discourse alignment, information, respect and emotional support, trust and specialty); healthcare system (trust and use of e-consultations) and context (media, peer pressure and social stigma). Conclusion: The decision to initiate medication in the pediatric population is multifactorial and influenced by perceptions on the disease and treatment, intrapersonal factors related to the caregivers and children, and interpersonal factors and factors related to the healthcare system and contexts. An informed, shared decision-making process that considers both the participation of children and the needs for support from caregivers when prescribing a treatment could promote initiation in the pediatric population.

Indexed as

medicationmedication adherencepatient participationpediatricsqualitative research

Identifiers

PMID40548053
PMCPMC12179087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.